Search
Enliven Therapeutics Inc
ELVNAdd to Watchlist
58.810USD
+0.750+1.29%
Close 08-14 16:00（ET）Quotes delayed by 15 min
4.31BMarket Cap
LossP/E TTM
ELVN Financials
See Enliven Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Enliven Therapeutics Inc Earnings Date
Latest Release
Aug 5, 2026
EPS / Forecast
-0.49/-0.40
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.83
3.24%
Analyst Rating
BUY
2026/08/14
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its current assets were 474.88M, with a year-on-year change of 49.27.
What are the total assets of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its total assets of Enliven Therapeutics Inc were 476.17M, with a year-on-year change of 46.17.
What are the total liabilities of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its total liabilities of Enliven Therapeutics Inc were 16.57M, with a year-on-year change of 4.10.
What is the total equity of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its total equity of Enliven Therapeutics Inc was 459.60M, with a year-on-year change of 48.33.
What is the net operating income of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its net operating income of Enliven Therapeutics Inc was -119.66M, with a year-on-year change of -14.45.
What is the net investment of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its net investment of Enliven Therapeutics Inc was -173.84M, with a year-on-year change of -382.93.
What is the net financing of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its net financing of Enliven Therapeutics Inc was 218.87M, with a year-on-year change of 64.36.
What is the Earnings Per Share (EPS) of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.83, with a year-on-year change of 3.24.
What is the net income of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its net income was -103.69M, with a year-on-year change of -16.48.
What is the Return on Equity (ROE) of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -26.95, with a year-on-year change of 15.87.
What is the Return on Assets (ROA) of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -25.86, with a year-on-year change of 13.20.
What is the operating profit of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its operating profit was -119.66M, with a year-on-year change of -14.45.